Blog

Observations from the Portfolio: Some Best Practices for Honest and Transparent Communications with Boards and Investors during the COVID-19 Crisis

April 30, 2020

The start-up ecosystem is powered by the potential of great success for companies, and high returns for investors. Entrepreneurs are trained to present opportunities, traction, and results in line with those expectations – yet falling into the trap of needing to appear to “crush it” all the time and give sugar-coated results and projections to […]

Read More

SINK OR SWIM Inside the Covid-19 Impact on Philadelphia’s Startups, Investors

April 27, 2020

Running a startup is hard. Talk to any founder and they’ll have a story about hard-fought survival and how grit or a few strokes of luck meant the difference between shutting their company’s doors or raising that next round of cash. During the Covid-19 pandemic, their jobs – and the work of investors who back […]

Read More

Ben Franklin Technology Partners Companies Affected by COVID-19 are Getting $4M From the State

April 27, 2020

Gov. Tom Wolf announced Thursday that Pennsylvania’s Department of Community and Economic Development (DCED) had made $4 million in new funding available to help tech-based companies in Ben Franklin Technology Partners’ (BFTP) portfolio that have been impacted by the COVID-19 pandemic. The funding will be distributed equally between the state’s four BFTP entities, which operate […]

Read More

Ben Franklin to Deploy $2M to Help Struggling Philly-Area Startups, but Funding Threat Looms

April 24, 2020

The most active seed fund in the Philadelphia region is preparing to deploy $2 million in new capital to help struggling startups stay afloat and help fight the Covid-19 pandemic, but a potential threat to its state funding looms in Harrisburg. Ben Franklin Technology Partners of Southeastern Pennsylvania, a state-backed nonprofit, announced late Thursday it […]

Read More

Cagent Vascular Announces FDA 510(k) Clearance for its Serranator Device for the Infrapopliteal Indication and Completion of its PRELUDE-BTK Clinical Trial Enrollment

April 23, 2020

WAYNE, Pa.–(BUSINESS WIRE)– Cagent Vascular, a developer of serration technology for vessel dilatation in cardiovascular disease interventions, announces FDA 510(k) Clearance of its Serranator® PTA Serration Balloon Catheter for treating below-the-knee (BTK) lesions. The Serranator device is the first and only angioplasty balloon FDA Cleared and CE Marked that embeds serration technology into a semi-compliant […]

Read More

Previous Next